论文部分内容阅读
目的:分析室性心律失常行胺碘酮联合琥珀酸美托洛尔缓释片急诊治疗的效果。方法:回顾性分析2012年7月-2015年7月于本院就诊的90例室性心律失常患者临床资料,按治疗时不同治疗方法分为两组,对照组38例行单药琥珀酸美托洛尔缓释片急诊治疗,观察组52例行胺碘酮联合琥珀酸美托洛尔缓释片急诊治疗,对比两组治疗效果。结果:观察组总有效96.15%比对照组73.68%高(P<0.05);观察组24 h短阵室性心动过速的发作次数与室性期收缩总次数均比对照组少(P<0.05)。结论:室性心律失常患者行胺碘酮联合琥珀酸美托洛尔缓释片急诊治疗的效果显著,可改善临床症状,减少室性心率失常的发作频率与时间。
Objective: To analyze the effect of amiodarone combined with metoprolol succinate sustained-release tablets in the treatment of ventricular arrhythmias. Methods: The clinical data of 90 patients with ventricular arrhythmia who were treated in our hospital from July 2012 to July 2015 were retrospectively analyzed. According to the different treatment methods, the patients were divided into two groups. The control group consisted of 38 single-agent succinic acid In the observation group, 52 cases were treated with amiodarone combined with metoprolol succinate sustained-release tablets for emergency treatment. The therapeutic effect was compared between the two groups. Results: The total effective rate in observation group was 96.15%, which was significantly higher than that in control group (73.68%, P <0.05). The number of episodes of 24 h episodes of ventricular tachycardia in observation group was lower than that in control group ). Conclusions: Amiodarone combined with Metoprolol Succinate sustained-release tablets in patients with ventricular arrhythmias can improve the clinical symptoms and reduce the frequency and duration of ventricular arrhythmia.